Global Glycomic Therapeutics Market Report 2024

Glycomic Therapeutics Global Market Report 2024 – By Class (Isolated, Synthetic), By Structures (Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans, Targeting Glycosphingolipids, Other Structures), By Mode Of Action (Inhibits Neuraminidase, Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate, Erythropoietin And Enzyme Replacement Therapy (ERT), Tissue Plasminogen Activator, Inhibits Glucosylceramide Synthase, Interleukin 1, 2 And 3, Beta And Gamma Interferons, Other Mode Of Action), By Indications – Market Size, Trends, And Global Forecast 2024-2033

Glycomic Therapeutics Global Market Report 2024

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs
Customise Your Report
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying
Glycomic Therapeutics Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Glycomic Therapeutics Market Definition And Segments

Glycomic therapeutics refers to the development of glycomics-based approaches in the field of therapeutics. Glycome is the complete set of glycans in a cell or organism, which is important for unraveling the complexity of biological systems and their implications for health and disease. Glycan plays important roles in various biological processes, including cell signaling, immune response, and disease development.

The main glycomic therapeutics class types are isolated, and synthetic. Isolated glycomic therapy refers to the study or analysis of glycans in isolation, focusing specifically on the structural and functional characterization of individual glycan molecules and the therapeutic approach that involves the use of synthetic glycans or glycan-based molecules for the diagnosis and treatment of diseases or medical conditions. The various structures are glycoproteins, targeting sialic acid, proteoglycans, targeting glycosaminoglycans, glycosylphosphatidylinositol (GPI)-anchored proteins and heparin based glycans, targeting glycosphingolipids, others with various mode of actions such as inhibits neuraminidase, inhibits heparanase and selectins and blocks interactions between growth factors and heparan sulfate, erythropoietin and enzyme replacement therapy (ERT), tissue plasminogen activator, inhibits glucosylceramide synthase, interleukin 1, 2 and 3, beta and gamma interferons, others. The various indications are thrombosis and chemoprophylaxis, anemia, anti-adhesive and anti-inflammatory, cataracts; Gaucher’s disease, mps-1 and IV, cancer, Alzheimer's disease, influenza type A and B, and others.

The glycomic therapeutics market covered in this report is segmented –

1) By Class: Isolated, Synthetic

2) By Structures: Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans, Targeting Glycosphingolipids, Other Structures

3) By Mode Of Action: Inhibits Neuraminidase, Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate, Erythropoietin And Enzyme Replacement Therapy (ERT), Tissue Plasminogen Activator, Inhibits Glucosylceramide Synthase, Interleukin 1, 2 And 3, Beta And Gamma Interferons, Other Mode Of Action

4) By Indications: Thrombosis And Chemoprophylaxis, Anemia, Anti-Adhesive And Anti-Inflammatory, Cataracts, Gaucher’s Disease, Mps-1 And IV, Cancer, Alzheimer’s Disease, Influenza Type A And B, Other Indications

The glycomic therapeutics market size has grown rapidly in recent years. It will grow from $141.31 billion in 2023 to $163.73 billion in 2024 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to increased awareness of glycan significance, rise in chronic diseases, drug development for rare diseases, collaborations in glycomics research.

The glycomic therapeutics market size is expected to see rapid growth in the next few years. It will grow to $301.03 billion in 2028 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to expanding knowledge of glycan biology, precision medicine approaches, rising interest in immunotherapy, increased funding for rare diseases research, emergence of glycan biomarkers. Major trends in the forecast period include expansion of glycomic applications in oncology, glycoengineering for enhanced therapeutic proteins, inclusion of glycomics in immuno-oncology, glycomics in rare and genetic disorders, regulatory considerations for glycomic drugs.

Rising Diabetes Prevalence Fuels Growth In The Glycomic Therapeutics Market

The increase in the prevalence of diabetes is expected to drive the growth of the glycomic therapeutics market. Diabetes is a chronic medical condition that affects the body's ability to regulate blood sugar (glucose) levels. In diabetes, alterations in glycans have been observed, which can contribute to insulin resistance and other metabolic abnormalities. Specific glycan patterns serve as biomarkers for diagnosing diabetes, predicting its progression, and monitoring treatment responses. For instance, in May 2023, according to the report published by the National Center for Health Statistics, a U.S.-based government agency that provides statistical information to guide actions and policies to improve the public health of the American people, the percentage of diagnosed diabetes for adults aged 18 and over, United States increased from 9.3% in 2020 to 9.6% in 2021. Therefore, the increase in the prevalence of diabetes is driving the growth of the glycomic therapeutics market.

Rising Cancer Prevalence Fuels Growth In The Glycomic Therapeutics Market

The increasing prevalence of cancer is expected to propel the growth of the glycomic therapeutics market going forward. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells in the body. Glycomic therapeutics are used in cancer treatment by targeting and modifying specific sugar molecules on cell surfaces, influencing critical cellular interactions, signaling pathways, and immune responses, with the aim of inhibiting tumor growth and enhancing the efficacy of cancer therapies. For instance, in 2023, according to a report published by the American Cancer Society, a US-based nationwide voluntary health organization dedicated to eliminating cancer, the estimated number of new cases of liver cancer in females diagnosed in the United States increased from 12,660 in 2022 to 13,230 in 2023. Therefore, the increasing prevalence of cancer is driving the growth of the glycomic therapeutics market.

Major companies operating in the glycomic therapeutics market report are F Hoffmann-La Roche Ltd., Bayer AG, Sanofi SA, Thermo Fisher Scientific Inc., GlaxoSmithKline PLC, Merck KGaA, ICON PLC, Agilent Technologies Inc., AMS Bio, Shimadzu Corporation, Waters Corporation, Bruker Corporation, BioMarin Pharmaceutical Inc., Bio Techne Corp., Promega Corporation, Halozyme Therapeutics Inc., Takara Bio Inc., Vector Laboratories, New England Biolabs Inc., Protalix Biotherapeutics Inc., Genovis AB, Ray Biotech Life Inc., IEC Group, Ludger Ltd., Z Biotech LLC, Alzheon Inc., GlycoMar Limited

Innovations In The Glycomic Therapeutics Market

Product innovation is a key trend gaining popularity in the glycomic therapeutics market. Major companies operating in the glycomic therapeutics sector are focused on developing new technological and innovative solutions to strengthen their position in the market. For instance, in April 2022, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical company is discovering advanced therapies, launched a novel fixed-dose combination (FDC) of a DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor), Teneligliptin, with Pioglitazone to improve glycemic control and to reduce insulin resistance in type 2 diabetes patients.

Screening Kits For Advanced Glycomic Therapeutics Exploration

Major companies operating in the glycomic therapeutics sector are focused on developing new technological and innovative solutions, such as screening kits to advance glycobiology research and exploration. A screening kit is essentially a pre-packaged set of tools and materials designed to perform a preliminary test for the presence or absence of a specific substance, condition, or property. For instance, in July 2022, Vector Laboratories, a US-based glycomic solutions provider company, launched Glysite Scout Glycan screening kits, which are fully integrated immunofluorescence kits for the detection of glycan expression in tissue sections. These kits will enable researchers to profile and characterise complex glycans in biological systems and detect the presence or absence of all major surface glycan motifs in a sample.

Halozyme Therapeutics Expands Portfolio With Acquisition Of Antares Pharma Inc.

In May 2022, Halozyme Therapeutics, a US-based biotechnology company, acquired Antares Pharma Inc. for $960 million. This purchase enhanced the pipeline portfolio of novel treatments employing its superior drug delivery methods, which have increased safety and efficacy, convenience, tolerability, and patient comfort and adherence. Antares Pharma Inc is a US-based pharmaceutical firm.

North America was the largest region in the glycomic therapeutics in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomic therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the glycomic therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The glycomic therapeutics market consists of sales of investigational glycomic therapeutics and therapeutic glycomic that target glycans or glycan-related pathways for the diagnosis and treatment of diseases. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The glycomic therapeutics market research report is one of a series of new reports from The Business Research Company that provides glycomic therapeutics market statistics, including glycomic therapeutics industry global market size, regional shares, competitors with a glycomic therapeutics market share, detailed glycomic therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the glycomic therapeutics industry. This glycomic therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Glycomic Therapeutics Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $163.73 billion
Revenue Forecast In 2033 $301.03 billion
Growth Rate CAGR of 16.4% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Class: Isolated, Synthetic
2) By Structures: Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans, Targeting Glycosphingolipids, Other Structures
3) By Mode Of Action: Inhibits Neuraminidase, Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate, Erythropoietin And Enzyme Replacement Therapy (ERT), Tissue Plasminogen Activator, Inhibits Glucosylceramide Synthase, Interleukin 1, 2 And 3, Beta And Gamma Interferons, Other Mode Of Action
4) By Indications: Thrombosis And Chemoprophylaxis, Anemia, Anti-Adhesive And Anti-Inflammatory, Cataracts, Gaucher’s Disease, Mps-1 And IV, Cancer, Alzheimer’s Disease, Influenza Type A And B, Other Indications
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled F Hoffmann-La Roche Ltd.; Bayer AG; Sanofi SA; Thermo Fisher Scientific Inc.; GlaxoSmithKline plc; Merck KGaA; ICON plc; Agilent Technologies Inc.; AMS Bio; Shimadzu Corporation; Waters Corporation; Bruker Corporation; BioMarin Pharmaceutical Inc.; Bio Techne Corp.; Promega Corporation; Halozyme Therapeutics Inc.; Takara Bio Inc.; Vector Laboratories; New England Biolabs Inc.; Protalix Biotherapeutics Inc.; Genovis AB; Ray Biotech Life Inc.; IEC Group; Ludger Ltd; Z Biotech LLC; Alzheon Inc.; GlycoMar Limited
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Glycomic Therapeutics Market Characteristics

    3. Glycomic Therapeutics Market Trends And Strategies

    4. Glycomic Therapeutics Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Glycomic Therapeutics Market Size and Growth

    5.1. Global Glycomic Therapeutics Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Glycomic Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Glycomic Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Glycomic Therapeutics Market Segmentation

    6.1. Global Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Isolated

    Synthetic

    6.2. Global Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Glycoproteins

    Targeting Sialic Acid

    Proteoglycans

    Targeting Glycosaminoglycans

    Glycosylphosphatidylinositol (Gpi)-Anchored Proteins And Heparin Based Glycans

    Targeting Glycosphingolipids

    Other Structures

    6.3. Global Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Inhibits Neuraminidase

    Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate

    Erythropoietin And Enzyme Replacement Therapy (Ert)

    Tissue Plasminogen Activator

    Inhibits Glucosylceramide Synthase

    Interleukin 1, 2 And 3

    Beta And Gamma Interferons

    Other Mode Of Action

    6.4. Global Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Thrombosis And Chemoprophylaxis

    Anemia

    Anti-Adhesive And Anti-Inflammatory

    Cataracts

    Gaucher's Disease

    Mps-1 And Iv

    Cancer

    Alzheimer's Disease

    Influenza Type A And B

    Other Indications

    7. Glycomic Therapeutics Market Regional And Country Analysis

    7.1. Global Glycomic Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Glycomic Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Glycomic Therapeutics Market

    8.1. Asia-Pacific Glycomic Therapeutics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Glycomic Therapeutics Market

    9.1. China Glycomic Therapeutics Market Overview

    9.2. China Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Glycomic Therapeutics Market

    10.1. India Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Glycomic Therapeutics Market

    11.1. Japan Glycomic Therapeutics Market Overview

    11.2. Japan Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Glycomic Therapeutics Market

    12.1. Australia Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Glycomic Therapeutics Market

    13.1. Indonesia Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Glycomic Therapeutics Market

    14.1. South Korea Glycomic Therapeutics Market Overview

    14.2. South Korea Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Glycomic Therapeutics Market

    15.1. Western Europe Glycomic Therapeutics Market Overview

    15.2. Western Europe Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Glycomic Therapeutics Market

    16.1. UK Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Glycomic Therapeutics Market

    17.1. Germany Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Glycomic Therapeutics Market

    18.5. France Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Glycomic Therapeutics Market

    19.9. Italy Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Glycomic Therapeutics Market

    20.13. Spain Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Glycomic Therapeutics Market

    21.1. Eastern Europe Glycomic Therapeutics Market Overview

    21.2. Eastern Europe Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Glycomic Therapeutics Market

    22.1. Russia Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Glycomic Therapeutics Market

    23.1. North America Glycomic Therapeutics Market Overview

    23.2. North America Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Glycomic Therapeutics Market

    24.1. USA Glycomic Therapeutics Market Overview

    24.2. USA Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Glycomic Therapeutics Market

    25.1. Canada Glycomic Therapeutics Market Overview

    25.2. Canada Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Glycomic Therapeutics Market

    26.1. South America Glycomic Therapeutics Market Overview

    26.2. South America Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Glycomic Therapeutics Market

    27.1. Brazil Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Glycomic Therapeutics Market

    28.1. Middle East Glycomic Therapeutics Market Overview

    28.2. Middle East Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Glycomic Therapeutics Market

    29.1. Africa Glycomic Therapeutics Market Overview

    29.2. Africa Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Glycomic Therapeutics Market Competitive Landscape And Company Profiles

    30.1. Glycomic Therapeutics Market Competitive Landscape

    30.2. Glycomic Therapeutics Market Company Profiles

    30.2.1. F Hoffmann-La Roche Ltd.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Bayer AG

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Sanofi SA

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Thermo Fisher Scientific Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. GlaxoSmithKline plc

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Glycomic Therapeutics Market Other Major And Innovative Companies

    31.1. Merck KGaA

    31.2. ICON plc

    31.3. Agilent Technologies Inc.

    31.4. AMS Bio

    31.5. Shimadzu Corporation

    31.6. Waters Corporation

    31.7. Bruker Corporation

    31.8. BioMarin Pharmaceutical Inc.

    31.9. Bio Techne Corp.

    31.10. Promega Corporation

    31.11. Halozyme Therapeutics Inc.

    31.12. Takara Bio Inc.

    31.13. Vector Laboratories

    31.14. New England Biolabs Inc.

    31.15. Protalix Biotherapeutics Inc.

    32. Global Glycomic Therapeutics Market Competitive Benchmarking

    33. Global Glycomic Therapeutics Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Glycomic Therapeutics Market

    35. Glycomic Therapeutics Market Future Outlook and Potential Analysis

    35.1 Glycomic Therapeutics Market In 2028 - Countries Offering Most New Opportunities

    35.2 Glycomic Therapeutics Market In 2028 - Segments Offering Most New Opportunities

    35.3 Glycomic Therapeutics Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Glycomic Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Glycomic Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: F Hoffmann-La Roche Ltd. Financial Performance
  • Table 76: Bayer AG Financial Performance
  • Table 77: Sanofi SA Financial Performance
  • Table 78: Thermo Fisher Scientific Inc. Financial Performance
  • Table 79: GlaxoSmithKline plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Glycomic Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Glycomic Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: F Hoffmann-La Roche Ltd. Financial Performance
  • Figure 76: Bayer AG Financial Performance
  • Figure 77: Sanofi SA Financial Performance
  • Figure 78: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 79: GlaxoSmithKline plc Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Blood Cancer Drugs Global Market Report 2024 – By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan/Mabthera (Rituximab), Gleevec/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), Other Drugs), By Treatment Approaches (Key Findings, Chemotherapeutic, mAbs/Targeted Therapies, Immunotherapeutic) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cancer biologics Global Market Report 2024 – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, Other Applications), By Distribution Channel (Hospitals, Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Rituximab Biosimilars Global Market Report 2024 – By Route Of Administration (Subcutaneous, Intravenous, Molecular Type), By Application (Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Other Applications), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Mail Order) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Acute Myeloid Leukemia Global Market Report 2024 – By Treatment Type (Chemotherapy, Radiation therapy, Stem Cell Transplant, Targeted Therapy), By Chemotherapy (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, Hormonal Therapy), By Regimen (DC Regimen, AVD Regimen, VCD Regimen), By End-User (Hospital, Retails Drug Stores, Ambulatory Care Centers, Clinics) – Market Size, Trends, And Global Forecast 2024-2033
View Report
CAR-T Therapy Global Market Report 2024 – By Type (Monotherapy, Combination Therapy), By Target Antigen (CD19, CD22, BCMA, Other Target Antigens), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024 – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits,, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Other Types), By Prescription Mode (Prescription-based Testing Devices, Over-The-Counter (OTC) Testing Devices), By End User (Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024 – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits,, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Other Types), By Prescription Mode (Prescription-based Testing Devices, Over-The-Counter (OTC) Testing Devices), By End User (Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024 – By Product (Instrument, Reagent), By Technology (NASBA, HAD), By Application (Blood Screening, Infectious Disease Diagnostics, Cancer), By End-User (Hospital, Reference Laboratories, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the glycomic therapeutics market?

Glycomic therapeutics refers to the development of glycomics-based approaches in the field of therapeutics. Glycome is the complete set of glycans in a cell or organism, which is important for unraveling the complexity of biological systems and their implications for health and disease. Glycan plays important roles in various biological processes, including cell signaling, immune response, and disease development. For further insights on the glycomic therapeutics market, request a sample here

How will the glycomic therapeutics market drivers and restraints affect the glycomic therapeutics market dynamics? What forces will shape the glycomic therapeutics industry going forward?

The glycomic therapeutics market major growth driver - Rising Diabetes Prevalence Fuels Growth In The Glycomic Therapeutics Market. For further insights on the glycomic therapeutics market, request a sample here

What is the forecast market size or the forecast market value of the glycomic therapeutics market?

The glycomic therapeutics market size has grown rapidly in recent years. It will grow from $141.31 billion in 2023 to $163.73 billion in 2024 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to increased awareness of glycan significance, rise in chronic diseases, drug development for rare diseases, collaborations in glycomics research.. The glycomic therapeutics market size is expected to see rapid growth in the next few years. It will grow to $301.03 billion in 2028 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to expanding knowledge of glycan biology, precision medicine approaches, rising interest in immunotherapy, increased funding for rare diseases research, emergence of glycan biomarkers.. Major trends in the forecast period include expansion of glycomic applications in oncology, glycoengineering for enhanced therapeutic proteins, inclusion of glycomics in immuno-oncology, glycomics in rare and genetic disorders, regulatory considerations for glycomic drugs.. For further insights on the glycomic therapeutics market, request a sample here

How is the glycomic therapeutics market segmented?

The glycomic therapeutics market is segmented
1) By Class: Isolated, Synthetic
2) By Structures: Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans, Targeting Glycosphingolipids, Other Structures
3) By Mode Of Action: Inhibits Neuraminidase, Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate, Erythropoietin And Enzyme Replacement Therapy (ERT), Tissue Plasminogen Activator, Inhibits Glucosylceramide Synthase, Interleukin 1, 2 And 3, Beta And Gamma Interferons, Other Mode Of Action
4) By Indications: Thrombosis And Chemoprophylaxis, Anemia, Anti-Adhesive And Anti-Inflammatory, Cataracts, Gaucher’s Disease, Mps-1 And IV, Cancer, Alzheimer’s Disease, Influenza Type A And B, Other IndicationsFor further insights on the glycomic therapeutics market, request a sample here

Which region has the largest share of the glycomic therapeutics market? What are the other regions covered in the report?

North America was the largest region in the glycomic therapeutics in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomic therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the glycomic therapeutics market, request a sample here.

Who are the major players in the glycomic therapeutics market?

Major companies operating in the glycomic therapeutics market report are F Hoffmann-La Roche Ltd., Bayer AG, Sanofi SA, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Merck KGaA, ICON plc, Agilent Technologies Inc., AMS Bio, Shimadzu Corporation, Waters Corporation, Bruker Corporation, BioMarin Pharmaceutical Inc., Bio Techne Corp., Promega Corporation, Halozyme Therapeutics Inc., Takara Bio Inc., Vector Laboratories, New England Biolabs Inc., Protalix Biotherapeutics Inc., Genovis AB, Ray Biotech Life Inc., IEC Group, Ludger Ltd, Z Biotech LLC, Alzheon Inc., GlycoMar Limited For further insights on the glycomic therapeutics market, request a sample here.

What are the key trends in the glycomic therapeutics market?

Major trend in the glycomic therapeutics market - Innovations In The Glycomic Therapeutics Market. For further insights on the glycomic therapeutics market, request a sample here.

What are the major opportunities in the glycomic therapeutics market? What are the strategies for the glycomic therapeutics market?

For detailed insights on the major opportunities and strategies in the glycomic therapeutics market, request a sample here.

How does the glycomic therapeutics market relate to the overall economy and other similar markets?

For detailed insights on glycomic therapeutics market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the glycomic therapeutics industry?

For detailed insights on the mergers and acquisitions in the glycomic therapeutics industry, request a sample here.

What are the key dynamics influencing the glycomic therapeutics market growth? SWOT analysis of the glycomic therapeutics market.

For detailed insights on the key dynamics influencing the glycomic therapeutics market growth and SWOT analysis of the glycomic therapeutics industry, request a sample here.